Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Twin and triplet pregnancy

NICE guideline
Reference number: NG137
Published: 04 September 2019
Last updated: 09 April 2024

History

Guidance published

Equality impact assessment (PDF 164 KB)

Published:

09 April 2024
Consultation comments and responses (PDF 431 KB)

Published:

09 April 2024
Committee member list (PDF 174 KB)

Published:

09 April 2024

Stakeholder list updated

Stakeholder list (PDF 133 KB)

Published:

08 April 2024

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF version) (PDF 173 KB)

Published:

30 January 2024
Evidence review C (PDF 3.01 MB)

Published:

30 January 2024
Comments form (MSWord 41 KB)

Published:

30 January 2024
Equality and health inequalities assessment 3 (PDF 118 KB)

Published:

30 January 2024

Declaration of interests

Register of interests (PDF 1.24 MB)

Published:

29 January 2024

Committee meetings

Committee meeting
Minutes 1 (PDF 253 KB)

Published:

06 March 2023
Minutes 2 (PDF 182 KB)

Published:

18 July 2023
Minutes 3 (PDF 211 KB)

Published:

07 September 2023
Minutes 4 (PDF 223 KB)

Published:

27 September 2023
Minutes 5 (PDF 180 KB)

Published:

03 November 2023
Minutes 6 (PDF 258 KB)

Published:

27 November 2023

Scope published

Final scope (PDF 186 KB)

Published:

14 July 2023

Original development on 04 September 2019

Stakeholder list updated
Stakeholder list (PDF 130 KB)

Published:

04 September 2019
Declaration of interests
Register of interests (PDF 458 KB)

Published:

04 September 2019
Guidance published
Consultation comments and responses (PDF 531 KB)

Published:

04 September 2019
Committee member list (PDF 118 KB)

Published:

04 September 2019
Equality impact assessment 4 (PDF 130 KB)

Published:

04 September 2019
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 571 KB)

Published:

22 March 2019
Evidence review A1 (PDF 1.3 MB)

Published:

22 March 2019
Evidence review A2 (PDF 1.87 MB)

Published:

22 March 2019
Evidence review A3 (PDF 736 KB)

Published:

22 March 2019
Evidence review B1 (PDF 2.19 MB)

Published:

22 March 2019
Evidence review B2 (PDF 4.19 MB)

Published:

22 March 2019
Evidence review C1 (PDF 1.4 MB)

Published:

22 March 2019
Evidence review C2 (PDF 470 KB)

Published:

22 March 2019
Evidence review C3 (PDF 714 KB)

Published:

22 March 2019
Evidence review C4 (PDF 964 KB)

Published:

22 March 2019
Evidence review D (PDF 2.03 MB)

Published:

22 March 2019
Equality impact assessment 3 (PDF 141 KB)

Published:

22 March 2019
Draft guideline (PDF 571 KB)

Published:

22 March 2019
Supporting documentation Previous full guideline CG129 (PDF 4.27 MB)

Published:

22 March 2019
Supporting documentation A (PDF 140 KB)

Published:

22 March 2019
Supporting documentation B (PDF 289 KB)

Published:

22 March 2019
Supporting documentation C (PDF 621 KB)

Published:

22 March 2019
Comments form (MSWord 39 KB)

Published:

22 March 2019
Pre-consultation documents released
Search strategies (PDF 2.77 MB)

Published:

22 January 2019
Economic plan (PDF 142 KB)

Published:

22 January 2019
Review questions (PDF 205 KB)

Published:

22 January 2019
Scope published
Consultation comments and responses (PDF 329 KB)

Published:

07 December 2017
Committee member list (PDF 366 KB)

Published:

07 December 2017
Final scope (PDF 278 KB)

Published:

14 December 2018
Equality impact assessment 2 (PDF 132 KB)

Published:

07 December 2017
Draft scope consultation
Draft scope consultation
Comments form (MSWord 64 KB)

Published:

11 September 2017
Draft scope (PDF 333 KB)

Published:

11 September 2017
Equality impact assessment 1 (PDF 134 KB)

Published:

11 September 2017
Committee meeting
Minutes 1 (PDF 437 KB)

Published:

12 December 2017
Minutes 2 (PDF 361 KB)

Published:

22 January 2018
Minutes 3 (PDF 316 KB)

Published:

09 March 2018
Minutes 4 (PDF 285 KB)

Published:

16 April 2018
Minutes 5 (PDF 200 KB)

Published:

31 May 2018
Minutes 6 (PDF 223 KB)

Published:

16 July 2018
Minutes 7 ( Day 1 of 2) (PDF 249 KB)

Published:

10 September 2018
Minutes 7 (Day 2 of 2) (PDF 188 KB)

Published:

11 September 2018
Minutes 8 (PDF 159 KB)

Published:

10 December 2018
Minutes 9 (PDF 159 KB)

Published:

06 June 2019